Clinical Trial - Trial jRCT1031220613
Access comprehensive clinical trial information for jRCT1031220613 through Pure Global AI's free database. This phase not specified trial is sponsored by Takeshi Yamada and is currently Recruiting. The study focuses on colorectal cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT1031220613
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCT1031220613
Untitled Trial
Biomarker study of FTD/TPI and Bevacizumab as Salvage line chemotherapy for colorectal cancer. (TAS CC5 Study)
Study Focus
Observational
Sponsor & Location
Takeshi Yamada
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Malignant neoplasm of colon
Malignant neoplasm: Descending colon
Malignant neoplasm: Colon, unspecified
Malignant neoplasm: Ascending colon
Malignant neoplasm: Overlapping lesion of colon
Data Source
Japan Registry Clinical Trial
jRCT1031220613
Non-Device Trial